High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
about
High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@en
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@nl
type
label
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@en
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@nl
prefLabel
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@en
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@nl
P2093
P2860
P356
P1476
High-Dose Metformin Plus Temoz ...... ivo Compared with Monotherapy.
@en
P2093
Ji Hee Lim
Jung Eun Lee
Seung Ho Yang
Yong Kil Hong
P2860
P356
10.4143/CRT.2017.466
P577
2018-01-10T00:00:00Z